Stability and Efficacy of Mucoadhesive Eye Drops Containing Olopatadine HCl: Physicochemical, Functional, and Preclinical In Vivo Assessment
- PMID: 40284512
- PMCID: PMC12030226
- DOI: 10.3390/pharmaceutics17040517
Stability and Efficacy of Mucoadhesive Eye Drops Containing Olopatadine HCl: Physicochemical, Functional, and Preclinical In Vivo Assessment
Abstract
Background: The incorporation of polymers into drug delivery vehicles has been shown to be an effective strategy to prolong the residence time of active ingredients in the precorneal tear film and to increase ocular bioavailability. Objectives: The aim of this study was to develop novel, viscous eye drops containing olopatadine (OCH) as the active ingredient, polysaccharides hydroxypropyl guar gum (HPG), and sodium hyaluronate (SH), individually, and in combination as functional polymers. Methods: Viscous eye drops containing 0.1% OCH in combination with HPG (0.25%) and SH (0.4%), were prepared and evaluated for their physicochemical properties, rheological behavior, mucoadhesion, and preliminary stability. A novel rheological method was used to evaluate the resistance of the eye drops under simulated blinking conditions. In vivo efficacy was evaluated using an ocular itch test in mice to compare the formulations with a commercial product. Results: The formulations remained stable and transparent, with physicochemical parameters within acceptable ranges. Rheological studies confirmed pseudoplastic flow, with the HPG-SH combination exhibiting enhanced viscosity and shear-thinning properties for prolonged retention in the eye. Mucoadhesion was highest in SH-HPG formulations. During simulated blinking cycles, eye drops containing a combination of SH and HPG polymers fully regained their initial viscosity during the resting periods. Preliminary stability studies indicate that the formulated eye drops exhibit satisfactory physicochemical stability under various storage conditions. In vivo, OCH-SH and OCH-HPG-SH drops provided prolonged antipruritic and analgesic effects compared to the reference product. Conclusions: Polysaccharide-based innovative formulations improve OCH retention, enhancing therapeutic efficacy and patient compliance in the treatment of allergic conjunctivitis.
Keywords: eye drops; hydroxypropyl guar gum; mucoadhesivity; ocular itch test; olopatadine hydrochloride; rheological synergism; sodium hyaluronate; stability.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures



Similar articles
-
Synergism of polysaccharide polymers in antihistamine eye drops: Influence on physicochemical properties and in vivo efficacy.Int J Pharm. 2024 Apr 25;655:124033. doi: 10.1016/j.ijpharm.2024.124033. Epub 2024 Mar 23. Int J Pharm. 2024. PMID: 38522490
-
Formulation of olopatadine hydrochloride viscous eye drops - physicochemical, biopharmaceutical and efficacy assessment using in vitro and in vivo approaches.Eur J Pharm Sci. 2021 Nov 1;166:105906. doi: 10.1016/j.ejps.2021.105906. Epub 2021 Jun 9. Eur J Pharm Sci. 2021. PMID: 34118409
-
Safe and Effective Management of Dry Eye Symptoms with Hydroxypropyl Guar and Hyaluronic Acid Dual-Polymer Lubricating Eye Drops: A Review of Preclinical and Clinical Studies.Clin Ophthalmol. 2023 Dec 13;17:3883-3898. doi: 10.2147/OPTH.S428725. eCollection 2023. Clin Ophthalmol. 2023. PMID: 38105908 Free PMC article. Review.
-
Efficacy and safety of dual-polymer hydroxypropyl guar- and hyaluronic acid-containing lubricant eyedrops for the management of dry-eye disease: a randomized double-masked clinical study.Clin Ophthalmol. 2018 Dec 5;12:2499-2508. doi: 10.2147/OPTH.S177176. eCollection 2018. Clin Ophthalmol. 2018. PMID: 30584269 Free PMC article.
-
Propylene Glycol and Hydroxypropyl Guar Nanoemulsion - Safe and Effective Lubricant Eye Drops in the Management of Dry Eye Disease.Clin Ophthalmol. 2022 Oct 10;16:3311-3326. doi: 10.2147/OPTH.S377960. eCollection 2022. Clin Ophthalmol. 2022. PMID: 36237486 Free PMC article. Review.
References
-
- Leonardi A., Quintieri L., Presa I.J., LLoves J.M., Montero J., Benítez-del-Castillo J.M., Lestón F.J.S., González-Mancebo E., Asero R., Groblewska A. Allergic conjunctivitis management: Update on ophthalmic solutions. Curr. Allergy Asthma Rep. 2024;24:347–360. doi: 10.1007/s11882-024-01150-0. - DOI - PMC - PubMed
-
- Güven U.M., Başaran E. In vitro-in vivo evaluation of olopatadine incorporated chitosan nanoparticles for the treatment of ocular allergy. J. Drug Deliv. Sci. Technol. 2021;64:102518. doi: 10.1016/j.jddst.2021.102518. - DOI
-
- Račić A., Čalija B., Milić J., Dukovski B.J., Lovrić J., Dobričić V., Micov A., Vuković M., Stepanović-Petrović R., Krajišnik D. Formulation of olopatadine hydrochloride viscous eye drops–physicochemical, biopharmaceutical and efficacy assessment using in vitro and in vivo approaches. Eur. J. Pharm. Sci. 2021;166:105906. doi: 10.1016/j.ejps.2021.105906. - DOI - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials